Glass House Brands (GLAS) Enterprise Value (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Enterprise Value of -$19.8 million for Q1 2026, up 75.4% year-over-year from -$11.3 million in Q1 2025, and down 69.86% quarter-over-quarter from -$11.7 million in Q4 2025.
Glass House Brands (GLAS) Enterprise Value (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Enterprise Value for 7 consecutive years, with -$19.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 75.4% year-over-year to -$19.8 million; the TTM figure through Mar 2026 stood at -$19.8 million (up 75.4% YoY), while the FY2025 annual figure was -$11.7 million, up 84.52% from the prior year.
- Enterprise Value fell to -$19.8 million in Q1 2026 per GLAS's latest filing, from -$11.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$11.7 million in Q4 2025 and bottomed at -$89.2 million in Q2 2025.
- Historically, Enterprise Value has averaged -$41.5 million across 5 years, with a median of -$28.1 million in 2022.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 92.48% — and 2024, when it plunged 330.65%.
- Glass House Brands' Enterprise Value stood at -$18.4 million in 2022, then increased by 4.79% to -$17.5 million in 2023, then slumped by 330.65% to -$75.5 million in 2024, then soared by 84.52% to -$11.7 million in 2025, then slumped by 69.86% to -$19.8 million in 2026.
- Business Quant data shows GLAS's Enterprise Value at -$19.8 million in Q1 2026, -$11.7 million in Q4 2025, and -$21.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Glass House Brands | 830.21 Mn | 811.66 Mn | 15.77 Mn | -18.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.85 Mn |
| Dec 31, 2025 | -11.68 Mn |
| Sep 30, 2025 | -21.89 Mn |
| Jun 30, 2025 | -89.20 Mn |
| Mar 31, 2025 | -80.68 Mn |
| Dec 31, 2024 | -75.47 Mn |
| Sep 30, 2024 | -72.13 Mn |
| Jun 30, 2024 | -59.06 Mn |
| Mar 31, 2024 | -53.79 Mn |
| Dec 31, 2023 | -17.52 Mn |
| Sep 30, 2023 | -58.28 Mn |
| Jun 30, 2023 | -35.83 Mn |
| Mar 31, 2023 | -26.65 Mn |
| Dec 31, 2022 | -18.41 Mn |
| Sep 30, 2022 | -17.68 Mn |
| Jun 30, 2022 | -18.52 Mn |
| Mar 31, 2022 | -28.05 Mn |
| Dec 31, 2021 | -54.26 Mn |
| Sep 30, 2021 | -28.86 Mn |
| Jun 30, 2021 | -134.28 Mn |